![](/img/cover-not-exists.png)
The importance of imaging studies to monitor treatment with novel AR-targeted agents in metastatic castration resistant prostate cancer (mCRPC)
Heidegger, I., Kohl, T., Pfister, D., Friederike, H., Paffenholz, P., Heidenreich, A.Volume:
16
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(17)30125-2
Date:
March, 2017
File:
PDF, 214 KB
english, 2017